Khazal, S., Gill, J. B., Foglesong, J., Yedururi, S., Morani, A., Sui, D., … Daw, N. C. (2023). A phase 1 dose escalation trial of ex-vivo expanded allogeneic cord blood-derived natural killer cell immunotherapy for pediatric solid tumor malignancies. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 41).

Khazal, Sajad, Jonathan Benjamin Gill, Jessica Foglesong, Sireesha Yedururi, Ajaykumar Morani, Dawen Sui, Roland L. Bassett, et al. “A phase 1 dose escalation trial of ex-vivo expanded allogeneic cord blood-derived natural killer cell immunotherapy for pediatric solid tumor malignancies.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 41, 2023.

Khazal S, Gill JB, Foglesong J, Yedururi S, Morani A, Sui D, et al. A phase 1 dose escalation trial of ex-vivo expanded allogeneic cord blood-derived natural killer cell immunotherapy for pediatric solid tumor malignancies. In: JOURNAL OF CLINICAL ONCOLOGY. 2023.

Khazal, Sajad, et al. “A phase 1 dose escalation trial of ex-vivo expanded allogeneic cord blood-derived natural killer cell immunotherapy for pediatric solid tumor malignancies.” JOURNAL OF CLINICAL ONCOLOGY, vol. 41, no. 16, 2023.

Khazal S, Gill JB, Foglesong J, Yedururi S, Morani A, Sui D, Bassett RL, Gettys S, Tewari P, Mahadeo K, Gorlick RG, Shpall EJ, Rezvani K, Daw NC. A phase 1 dose escalation trial of ex-vivo expanded allogeneic cord blood-derived natural killer cell immunotherapy for pediatric solid tumor malignancies. JOURNAL OF CLINICAL ONCOLOGY. 2023.